Overall Survival of Filipino Patients with Squamous Cell Carcinoma of the Head and Neck: A Single-Institution Experience

被引:8
|
作者
Albano, Pia Marie [1 ,2 ,3 ]
Lumang-Salvador, Christianne [6 ]
Orosa, Jose, III [6 ]
Racelis, Sheryl [7 ]
Leano, Modesty [7 ]
Angeles, Lara Mae [3 ,5 ]
Ramos, John Donnie [1 ,3 ,4 ]
机构
[1] Univ Santo Tomas, Res Ctr Nat & Appl Sci, Manila, Philippines
[2] Univ Santo Tomas, Dept Nat Sci, Coll Nursing, Manila, Philippines
[3] Univ Santo Tomas, Grad Sch, Manila, Philippines
[4] Univ Santo Tomas, Coll Sci, Dept Biol Sci, Manila, Philippines
[5] Univ Santo Tomas Hosp, Dept Clin Pathol, Manila, Philippines
[6] Mariano Marcos Mem Hosp & Med Ctr, Dept ENT Head & Neck Surg, Ilocos Norte, Philippines
[7] Mariano Marcos Mem Hosp & Med Ctr, Dept Pathol, Ilocos Norte, Philippines
关键词
Squamous cell carcinoma of the head and neck; survival; treatment; tumor stage; Philippines; HUMAN-PAPILLOMAVIRUS; CANCER INCIDENCE; ORAL-CAVITY; TRENDS; COUNTRIES; MORTALITY;
D O I
10.7314/APJCP.2013.14.8.4769
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This paper is the first to present the incidence and overall survival of patients with squamous cell carcinoma of the head and neck (SCCHN) from the extreme northern part of the Philippines. We retrospectively retrieved the records of patients with histologically-confirmed squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx and larynx at the Mariano Marcos Memorial Hospital and Medical Center, Ilocos Norte, Philippines, from 2003 to 2012 and analysed prognostic factors associated with survival. Of the 150 cases, only 80 (53.3%) were still living when the study was terminated. Median age at initial diagnosis was 61.5 years and the male to female ration was 7:3. The majority of the cases had tumours in the oral cavity (50.7%), followed by the larynx (36.7%). Sex (log rank=1.94, p value/alpha=0.16), tumor site (log rank=0.02, p value/alpha=0.90), tumor grade (log rank=1.74, p value/alpha=0.42). and node state (log rank=0.07, p value/alpha=0.80) were not shown to be associated with the survival of our cases. Only 45 (30.0%) had no regional lymph node involvement (N0) at presentation and 12 (8.0%) had already developed distant metastases. Among the 150 patients, 71 (47.3%) were not able to receive treatment of any kind. Oddly, treatment (log rank=1.65, p value/alpha=0.20) was also shown to be not associated with survival. The survival rate of those who underwent surgery, radiotherapy, of both was not statistically different from those who did not receive any treatment. Only the tumor state (log rank=4.51, p value/alpha=0.03) was associated with patient survival. The overall mean survival was 49.3 months, with survival rate diminishing from 88.3% during the 1st year to 1.80% by end of the study. This relatively low survival rate of our cases only reflects their poor access to quality diagnostic and treatment facilities.
引用
收藏
页码:4769 / 4774
页数:6
相关论文
共 50 条
  • [41] Clinicopathologic and survival analysis of patients with adenoid cystic carcinoma of vulva: single-institution experience
    Zhu, Jun
    Yin, Lina
    Wang, Qifeng
    Wu, Xiaohua
    Ke, Guihao
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (12) : 2144 - 2150
  • [42] Thiazolidinedione (TZD) exposure and overall survival (OS) in squamous cell carcinoma of the head and neck (SCCHN)
    Govindarajan, R.
    Siegel, E. R.
    Simmons, D. L.
    Lang, N. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [43] SULF2 expression is prognostic for overall survival in Head and Neck Squamous Cell Carcinoma
    Yang, Yang
    Ahn, Jaeil
    Kallakury, Bhaskar V.
    Brnakova, Zuzana
    Davidson, Bruce J.
    Goldman, Radoslav
    GLYCOBIOLOGY, 2018, 28 (12) : 1068 - 1069
  • [44] Low expression of RalGAPs associates with the poorer overall survival of head and neck squamous cell carcinoma
    Liu, Shan
    Shi, Congyu
    Wang, Xiaoyi
    Ma, Xiangrui
    Gao, Pan
    TRANSLATIONAL CANCER RESEARCH, 2021, 10 (12) : 5085 - +
  • [45] A Glycosyltransferase-Related Signature for Predicting Overall Survival in Head and Neck Squamous Cell Carcinoma
    Wu, Huili
    Zhao, Xiao
    Zhu, Tingting
    Rong, Di
    Wang, Ying
    Leng, Diya
    Wu, Daming
    FRONTIERS IN GENETICS, 2022, 13
  • [46] Gender disparities among race in the incidence and overall survival of head and neck squamous cell carcinoma
    Naik, A. N.
    Mazul, A.
    Zhan, K. Y.
    Puram, S. V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (05): : 1159 - 1159
  • [47] Paclitaxel is effective in relapsed head and neck squamous cell carcinoma: a retrospective study of 66 patients at a single institution
    Fayette, Jerome
    Montella, Anthony
    Chabaud, Sylvie
    Bachelot, Thomas
    Pommier, Pascal
    Girodet, Didier
    Racadot, Severine
    Montbarbon, Xavier
    Favier, Bertrand
    Zrounba, Philippe
    ANTI-CANCER DRUGS, 2010, 21 (05) : 553 - 558
  • [48] Assessment of Turnaround Time (TAT) for Oral Squamous Cell Carcinoma Biopsies: A Single-Institution Experience
    Priyadharshini, G.
    Ramalingam, Karthikeyan
    Ramani, Pratibha
    Nallaswamy, Deepak
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (06)
  • [49] Clinical Profile and Treatment Outcome of Squamous Cell Carcinoma (SCC) Hypopharynx: A Single-Institution Experience
    Resmi, R.
    Kumar, R. R.
    Kainickal, C. T.
    Rafi, M.
    Azariah, B. M.
    Kunnambath, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E317 - E317
  • [50] EGFR Inhibitors in Patients with Advanced Squamous Cell Anal Carcinomas: A Single-Institution Experience
    Kim, Dae Won
    Byer, Jennifer
    Kothari, Nishi
    Mahipal, Amit
    Chang, Yound Doo
    Kim, Richard D.
    ONCOLOGY, 2017, 92 (04) : 190 - 196